SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-019213
Filing Date
2016-05-12
Accepted
2016-05-12 14:58:41
Documents
53
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q myok-10q_20160331.htm 10-Q 1307388
2 EX-10.2 myok-ex102_242.htm EX-10.2 170710
3 EX-31.1 myok-ex311_6.htm EX-31.1 15954
4 EX-31.2 myok-ex312_9.htm EX-31.2 15938
5 EX-32.1 myok-ex321_7.htm EX-32.1 11237
  Complete submission text file 0001564590-16-019213.txt   3997241

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT myok-20160331.xml EX-101.INS 642264
7 XBRL TAXONOMY EXTENSION SCHEMA myok-20160331.xsd EX-101.SCH 35355
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE myok-20160331_cal.xml EX-101.CAL 29809
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE myok-20160331_def.xml EX-101.DEF 83347
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE myok-20160331_lab.xml EX-101.LAB 244667
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myok-20160331_pre.xml EX-101.PRE 179431
Mailing Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-741-0900
MyoKardia Inc (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37609 | Film No.: 161643287
SIC: 2834 Pharmaceutical Preparations